UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055024
Receipt number R000061163
Scientific Title Usefulness of Touki-Peonyaku-San in the treatment of fatigue in patients with chronic heart failure
Date of disclosure of the study information 2024/08/01
Last modified on 2025/01/19 11:39:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An observational study to evaluate the efficacy and safety of Touki-Peonyaku-San for the treatment of fatigue in patients with chronic heart failure

Acronym

Usefulness of Touki-Peonyaku-San in the treatment of fatigue in heart failure

Scientific Title

Usefulness of Touki-Peonyaku-San in the treatment of fatigue in patients with chronic heart failure

Scientific Title:Acronym

Usefulness of Touki-Peonyaku-San in the treatment of fatigue in heart failure

Region

Japan


Condition

Condition

chronic heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the safety and efficacy of tokishakuyakusan for the treatment of fatigue in patients with heart failure

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

KCCQ-12subtitle(3); Comparison at the start of treatment, around 4 weeks after the start of treatment, and around 9 weeks after the start of treatment

Key secondary outcomes

KCCQ-12 summary score, KCCQ-12 domain scores(KCCQ12-PL, KCCQ12-SF, KCCQ12-QL, KCCQ12-SL),VAS(fatigue, sense of cold, diziness, palpitation, loss of appetite),labotratotry data(BNP, Cr, eGFR, Hb, Hct, Alb, Na, K, Cl), severeity of leg edema, cardio-thoracic ratio assessed by chest x-ray (CTR)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with chronic heart failure who have moderate or severe fatigue (as judged by the physician) and for whom TJ-23 is prescribed in the cardiology outpatient clinic

Key exclusion criteria

Patients less than 20 years of age, no more than moderate (as judged by the physician) fatigue at the start of TJ-23 will be excluded. Since this study will be conducted on an opt-out basis, patients will be excluded if they request to be excluded from the study

Target sample size

14


Research contact person

Name of lead principal investigator

1st name Neiko
Middle name
Last name Ozasa

Organization

Kyoto University Hospital

Division name

Kampo Medical Unit

Zip code

606-8507

Address

54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto City, Kyoto, JAPAN

TEL

0757514899

Email

nei126@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Neiko
Middle name
Last name Ozasa

Organization

Kyoto University Hospital

Division name

Kampo Medical Unit

Zip code

606-8507

Address

54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto City, Kyoto, JAPAN

TEL

0757514899

Homepage URL


Email

nei126@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

National Institute of Biomedical Research and Innovation (NIBIO)

Institute

Department

Personal name

Neiko Ozasa


Funding Source

Organization

TSUMURA & CO.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Gradate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN

Tel

0757534680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2024 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 07 Month 18 Day

Date of IRB

2024 Year 07 Month 18 Day

Anticipated trial start date

2024 Year 08 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry

2024 Year 12 Month 31 Day

Date trial data considered complete

2024 Year 12 Month 31 Day

Date analysis concluded

2026 Year 03 Month 31 Day


Other

Other related information

A single-center, retrospective, observational study to evaluate the safety and efficacy of Touki-shakuyaku-san for the treatment of fatigue in patients with chronic heart failure


Management information

Registered date

2024 Year 07 Month 19 Day

Last modified on

2025 Year 01 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061163